Trials / Terminated
TerminatedNCT01886300
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam
A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating Sustained Response in Subjects With HBeAg Positive Chronic Hepatitis B Receiving Therapy With Pegasys (Peginterferon Alfa-2a) in Vietnam
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective, multicenter, observational study will evaluate the sustained response in patients with HBeAg positive chronic hepatitis B who are treated with Pegasys according to standard of care and in line with the current local labeling in routine clinical practice in Vietnam. Eligible patients will be followed for the duration of their treatment and for up to 2 years thereafter.
Conditions
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2013-06-25
- Last updated
- 2016-06-22
- Results posted
- 2016-06-22
Locations
3 sites across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT01886300. Inclusion in this directory is not an endorsement.